Tactile Systems Technology, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Tactile Systems Technology, Inc. (TCMD) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $900.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-05-04
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $900.00K, a 0.00% change year-over-year.
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $900.00K, a 0.00% change year-over-year.
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $900.00K, a 0.00% change year-over-year.
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $900.00K, a 0.00% change year-over-year.
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $3.60M, a 2.86% increase from fiscal 2024.
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $3.50M, a 2.78% decline from fiscal 2023.
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $3.60M, a 5.26% decline from fiscal 2022.
- Tactile Systems Technology, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $3.80M, a 5.56% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $900.00K 10-Q · filed 2026-05-04 | $1.80M derived: sum of 2 quarters · filed 2026-05-04 | $2.70M derived: sum of 3 quarters · filed 2026-05-04 | $3.60M derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.80M derived: sum of 2 quarters · filed 2026-02-17 | $2.70M derived: sum of 3 quarters · filed 2026-02-17 | $3.60M 10-K · filed 2026-02-17 |
| 2025-09-30 | $900.00K 10-Q · filed 2025-11-03 | $1.80M derived: sum of 2 quarters · filed 2025-11-03 | $2.70M 10-Q · filed 2025-11-03 | $3.60M derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-06-30 | $900.00K 10-Q · filed 2025-08-04 | $1.80M 10-Q · filed 2025-08-04 | $2.70M derived: sum of 3 quarters · filed 2026-05-04 | $3.60M derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-03-31 | $900.00K 10-Q · filed 2026-05-04 | $1.80M derived: sum of 2 quarters · filed 2026-05-04 | $2.70M derived: sum of 3 quarters · filed 2026-05-04 | $3.60M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.80M derived: sum of 2 quarters · filed 2026-02-17 | $2.70M derived: sum of 3 quarters · filed 2026-02-17 | $3.50M 10-K · filed 2026-02-17 |
| 2024-09-30 | $900.00K 10-Q · filed 2025-11-03 | $1.80M derived: sum of 2 quarters · filed 2025-11-03 | $2.60M 10-Q · filed 2025-11-03 | $3.60M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $900.00K 10-Q · filed 2025-08-04 | $1.80M 10-Q · filed 2025-08-04 | $2.70M derived: sum of 3 quarters · filed 2026-02-17 | $3.60M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $900.00K 10-Q · filed 2025-05-05 | $1.80M derived: sum of 2 quarters · filed 2026-02-17 | $2.70M derived: sum of 3 quarters · filed 2026-02-17 | $3.60M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.80M derived: sum of 2 quarters · filed 2026-02-17 | $2.70M derived: sum of 3 quarters · filed 2026-02-17 | $3.60M 10-K · filed 2026-02-17 |
| 2023-09-30 | $900.00K 10-Q · filed 2024-11-04 | $1.80M derived: sum of 2 quarters · filed 2024-11-04 | $2.70M 10-Q · filed 2024-11-04 | $3.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $900.00K 10-Q · filed 2024-08-05 | $1.80M 10-Q · filed 2024-08-05 | $2.80M derived: sum of 3 quarters · filed 2025-02-18 | $3.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $900.00K 10-Q · filed 2024-05-06 | $1.90M derived: sum of 2 quarters · filed 2025-02-18 | $2.80M derived: sum of 3 quarters · filed 2025-02-18 | $3.80M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.90M derived: sum of 2 quarters · filed 2025-02-18 | $2.90M derived: sum of 3 quarters · filed 2025-02-18 | $3.80M 10-K · filed 2025-02-18 |
| 2022-09-30 | $900.00K 10-Q · filed 2023-11-06 | $1.90M derived: sum of 2 quarters · filed 2023-11-06 | $2.80M 10-Q · filed 2023-11-06 | $3.90M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-07 | $1.90M 10-Q · filed 2023-08-07 | $3.00M derived: sum of 3 quarters · filed 2024-02-20 | $3.90M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-08 | $2.00M derived: sum of 2 quarters · filed 2024-02-20 | $2.90M derived: sum of 3 quarters · filed 2024-02-20 | $3.70M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $1.90M derived: sum of 2 quarters · filed 2024-02-20 | $2.70M derived: sum of 3 quarters · filed 2024-02-20 | $3.60M 10-K · filed 2024-02-20 |
| 2021-09-30 | $900.00K 10-Q · filed 2022-11-07 | $1.70M derived: sum of 2 quarters · filed 2022-11-07 | $2.60M 10-Q · filed 2022-11-07 | $3.40M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $800.00K 10-Q · filed 2022-08-01 | $1.70M 10-Q · filed 2022-08-01 | $2.50M derived: sum of 3 quarters · filed 2023-02-21 | $3.30M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $800.00K 10-Q · filed 2022-05-02 | $1.70M derived: sum of 2 quarters · filed 2023-02-21 | $2.50M derived: sum of 3 quarters · filed 2023-02-21 | |
| 2020-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $1.70M derived: sum of 2 quarters · filed 2023-02-21 | $3.00M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $800.00K 10-Q · filed 2021-11-08 | $2.10M 10-Q · filed 2021-11-08 | ||
| 2019-12-31 | $2.10M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |